Search Results 321-330 of 4639 for 搜索引擎查看咨询邮箱:lgooxc@hotmail.com
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Email: tang.paul2@mayo.edu. Ieng Lam Lei, Ph.D. Co-investigator; Email: lei.ienglam@mayo.edu. Social Media. Follow Dr. Tang and his lab's research on X. More ...
Study of BMF-219, in Adult Patients With Acute Leukemia (AL), Diffuse Large B-cell Lymphoma (DLBCL), Multiple Myeloma (MM), and Chronic Lymphocytic Leukemia ...
See an overview of Benefactor-Funded Research Established-Investigator Career Awards through Mayo Clinic's Center for Clinical and Translational Science ...
July 02, 2025. A publication for physicians that explores trends and information related to Department of Surgery specialties at Mayo Clinic.
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers. We ...
Human Immunodeficiency Virus Laboratory · Mayo Clinic Guggenheim Building, Room 501 200 First St. SW Rochester, MN 55905 · Phone: 507-284-9646 · Email: ...
Interventions to support clinical decision-making and patient-clinician shared decision-making. Venous thromboembolism risk stratification. Transplant patient ...
A Study to Evaluate Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for Multiple Myeloma with Minimal Residual Disease (MRD) to Direct Therapy ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.